US bio-chemicals firm OPX Biotechnologies secures first tranche of $45 million Series C round
By CEP Staff • 7 July 2011 in
News
US bio-chemicals firm OPX Biotechnologies secures first tranche of $45 million Series C round
Not already a subscriber?
As a subscriber, you have reached this page because you are not logged in.